-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
$20 Million Bet On Precigen? Check Out These 4 Penny Stocks Insiders Are Buying
$20 Million Bet On Precigen? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones jumped more than 350 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Precigen
- The Trade: Precigen, Inc. (NASDAQ:PGEN) Director Randal J Kirk bought a total of 11,428,571 shares at an average price of $1.75. To acquire these shares, it cost around $20 million .
- What's Happening: Precigen recently announced a proposed $75 million public offering of common stock.
- What Precigen Does: Precigen Inc is a biotechnology company that develops synthetic biology solutions.
Yellow
- The Trade: Yellow Corporation (NASDAQ:YELL) Director Chris T Sultemeier acquired a total 66,594 shares at an average price of $4.25. The insider spent around $123.28 thousand to buy those shares.
- What's Happening: Yellow Corporation is expected to report Q4 results on Thursday, Feb. 9, 2023.
- What Yellow Does: Yellow Corp is engaged in offering transportation services. It has a comprehensive less-than-truckload (LTL) networks in North America with local, regional, national, and international capabilities.
Check This Out: Meta Platforms To Report Earnings After Closing Bell, Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
GeneDx Holdings
- The Trade: GeneDx Holdings Corp. (NASDAQ:WGS) 10% owner Opko Health Inc acquired a total of 14,285,714 shares at an average price of $0.35. To acquire these shares, it cost around $5 million.
- What's Happening: GeneDx Holdings recently priced its public offering of 428,571,429 shares of common stock at $0.35 per share.
- What GeneDx Holdings Does: Sema4 Holdings Corp is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights.
Don't forget to check out our premarket coverage here
Jasper Therapeutics
- The Trade: Jasper Therapeutics, Inc. (NASDAQ:JSPR) 10% owner Carlyle Genesis UK LLC acquired a total of 3,133,333 shares at an average price of $1.50. The insider spent $4.7 million to buy those shares.
- What's Happening: Jasper Therapeutics recently priced its 60 million share offering at $1.50 per share.
- What Jasper Therapeutics Does: Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy.
The Dow Jones jumped more than 350 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道瓊斯週二跳了超過 350 點。當內部人士購買或出售股票時,表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以認為這是他們整體投資或交易決策的一個因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是最近一些細價股的著名內幕交易。欲了解更多信息,請查看 本辛加的內幕交易 平台。
Precigen
高精度
- The Trade: Precigen, Inc. (NASDAQ:PGEN) Director Randal J Kirk bought a total of 11,428,571 shares at an average price of $1.75. To acquire these shares, it cost around $20 million .
- What's Happening: Precigen recently announced a proposed $75 million public offering of common stock.
- What Precigen Does: Precigen Inc is a biotechnology company that develops synthetic biology solutions.
- 貿易: 普雷希根股份有限公司 (納斯達克:PGEN) 董事蘭達爾 Ĵ 柯克 買入總共 11 萬 5 千五百七十一股 平均價格為 1.75 美元。要收購這些股份,它的成本約為 2,000 萬美元。
- 發生了什麼事: 普雷西根最近宣布了一項建議進行 7,500 萬美元的普通股公開發行。
- 什麼是寶貴的作用: Precegen Inc 是一家開發合成生物學解決方案的生物技術公司。
Yellow
黃色
- The Trade: Yellow Corporation (NASDAQ:YELL) Director Chris T Sultemeier acquired a total 66,594 shares at an average price of $4.25. The insider spent around $123.28 thousand to buy those shares.
- What's Happening: Yellow Corporation is expected to report Q4 results on Thursday, Feb. 9, 2023.
- What Yellow Does: Yellow Corp is engaged in offering transportation services. It has a comprehensive less-than-truckload (LTL) networks in North America with local, regional, national, and international capabilities.
- 貿易: 黃色公司 (納斯達克:耶爾) 導演克里斯 ·T· 蘇特邁爾 購入合共 66,594 股股份 平均價格為 4.25 美元。內部人士花費了大約 123.28 萬美元購買這些股票。
- 發生了什麼: 黃色公司預計將於 2023 年 2 月 9 日(星期四)公佈第四季業績。
- 什麼黃色:黃光股份有限公司從事提供運輸服務。它在北美擁有全面的低卡車負載(LTL)網絡,具有本地,區域,國家和國際能力。
Check This Out: Meta Platforms To Report Earnings After Closing Bell, Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
看看這個: 元平台將在收盤後報告收益,以下是最準確的分析師最近的價格目標變化
GeneDx Holdings
天滙控股
- The Trade: GeneDx Holdings Corp. (NASDAQ:WGS) 10% owner Opko Health Inc acquired a total of 14,285,714 shares at an average price of $0.35. To acquire these shares, it cost around $5 million.
- What's Happening: GeneDx Holdings recently priced its public offering of 428,571,429 shares of common stock at $0.35 per share.
- What GeneDx Holdings Does: Sema4 Holdings Corp is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights.
- 貿易: 一源控股股份有限公司 (納斯達克:WGS)10% 的所有者奧科健康公司 購入合共 14,285、714 股股份 平均價格為 0.35 美元。要收購這些股份,成本約為 500 萬元。
- 發生了什麼: 捷然控股最近以每股 0.35 美元的價格定價為 428,571,429 股普通股的公開發行。
- 創毅控股有什麼作用: Sema4 控股公司是一家以患者為中心的健康情報公司,致力於通過數據驅動的見解來促進醫療保健。
Don't forget to check out our premarket coverage here
不要忘記在這裡查看我們的售前覆蓋範圍
Jasper Therapeutics
碧玉治療
- The Trade: Jasper Therapeutics, Inc. (NASDAQ:JSPR) 10% owner Carlyle Genesis UK LLC acquired a total of 3,133,333 shares at an average price of $1.50. The insider spent $4.7 million to buy those shares.
- What's Happening: Jasper Therapeutics recently priced its 60 million share offering at $1.50 per share.
- What Jasper Therapeutics Does: Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy.
- 貿易: 碧玉治療, 公司. (納斯達克:JSPR)10% 所有者凱雷創世紀英國有限責任公司 購入股份共三百三十三萬三百三十三股 平均價格為 1.50 美元。內幕人士花了 470 萬美元購買這些股票。
- 發生了什麼:碧玉治療最近以每股 1.50 美元的價格定價 6000 萬股。
- 碧玉治療做什麼: 碧玉治療公司是一家臨床階段的生物技術公司,致力於通過造血幹細胞療法實現治療。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧